• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Verastem, Inc. - Common Stock (NQ:VSTM)

    5.680 -0.030 (-0.53%)
    Streaming Delayed Price Updated: 9:30 AM EST, Feb 19, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 21,721
    Open 5.730
    Bid (Size) 5.660 (100)
    Ask (Size) 5.720 (100)
    Prev. Close 5.710
    Today's Range 5.680 - 5.730
    52wk Range 4.010 - 11.24
    Shares Outstanding 44,784,000
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Verastem Oncology to Report Fourth Quarter and Full Year 2025 Financial Results on March 4, 2026
    From Verastem Oncology
    Via Business Wire
    News headline image
    Verastem Oncology Provides Preliminary Fourth Quarter and 2025 Revenue and Business Updates and Outlines 2026 Strategic Priorities for Novel Portfolio Targeting RAS/MAPK Pathway-Driven Cancers
    From Verastem Oncology
    Via Business Wire

    Performance

    YTD
    -21.4%
    -21.4%
    1 Month
    -14.6%
    -14.6%
    3 Month
    -38.7%
    -38.7%
    6 Month
    -31.7%
    -31.7%
    1 Year
    -1.0%
    -1.0%

    More News

    Read More
    News headline image
    Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Verastem Oncology
    Via Business Wire
    News headline image
    Earnings Scheduled For November 4, 2025 ↗
    Via Benzinga
    Verastem Stock Ignites Retail Buzz After Early Cancer Drug Data Show Tumor Reduction, Mild Side Effects ↗
    Via Stocktwits
    News headline image
    This Biotech Fund Exited an $8 Million Edgewise Stake as the Stock Slid Double Digits ↗
    Via The Motley Fool
    News headline image
    Verastem Oncology Stock Drops After Hours After Discontinuing A Clinical Trial In Lung Cancer ↗
    Via Stocktwits
    Topics Supply Chain
    News headline image
    Verastem Oncology Provides Update on RAMP 203 Phase 1/2 Clinical Trial for Advanced KRAS G12C Mutant Non-Small Cell Lung Cancer
    From Verastem Oncology
    Via Business Wire
    News headline image
    This Biotech Is Up 194% in a Year but One Investor Took Millions Off the Table ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    ANI Stock Is Up 49% This Past Year, Revenue Is Surging, and One Fund Still Walked Away ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Verastem Oncology Announces Strategic Transition Plan to Accelerate Next Phase of Growth
    From Verastem Oncology
    Via Business Wire
    News headline image
    Verastem Oncology to Present at the 8th Annual Evercore Healthcare Conference
    From Verastem Oncology
    Via Business Wire
    News headline image
    Red Cat Posts Downbeat Q3 Results, Joins StubHub, WhiteFiber And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    Verastem Oncology Announces Pricing of $90 Million Public Offering of Common Stock and Pre-Funded Warrants
    From Verastem Oncology
    Via Business Wire
    News headline image
    Verastem Oncology Announces Proposed Public Offering of Common Stock
    From Verastem Oncology
    Via Business Wire
    News headline image
    Verastem Oncology to Present at Upcoming Investor Conferences
    From Verastem Oncology
    Via Business Wire
    News headline image
    Verastem Inc (NASDAQ:VSTM) Reports Q3 2025 Revenue Beat Amid Widened Loss ↗
    Via Chartmill
    News headline image
    Verastem Oncology Reports Third Quarter 2025 Financial Results and Highlights Recent Business Updates
    From Verastem Oncology
    Via Business Wire
    News headline image
    Verastem Oncology Announces Encouraging Preliminary Data from Ongoing Phase 1/2a Dose Escalation Trial of VS-7375, an Oral KRAS G12D (ON/OFF) Inhibitor, in Patients with KRAS G12D Mutant Solid Tumors
    From Verastem Oncology
    Via Business Wire
    News headline image
    Verastem Oncology to Report Third Quarter 2025 Financial Results on November 4, 2025
    From Verastem Oncology
    Via Business Wire
    News headline image
    Verastem Oncology Announces Updated Data from Partner GenFleet Therapeutics’ Phase 1/2 Monotherapy Study in China of GFH375 (VS-7375) in Advanced KRAS G12D Mutant Pancreatic Ductal Adenocarcinoma
    From Verastem Oncology
    Via Business Wire
    News headline image
    Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Verastem Oncology
    Via Business Wire
    News headline image
    Verastem Oncology to Present at Upcoming Investor Conferences
    From Verastem Oncology
    Via Business Wire
    News headline image
    12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
    Via Benzinga

    Frequently Asked Questions

    Is Verastem, Inc. - Common Stock publicly traded?
    Yes, Verastem, Inc. - Common Stock is publicly traded.
    What exchange does Verastem, Inc. - Common Stock trade on?
    Verastem, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Verastem, Inc. - Common Stock?
    The ticker symbol for Verastem, Inc. - Common Stock is VSTM on the Nasdaq Stock Market
    What is the current price of Verastem, Inc. - Common Stock?
    The current price of Verastem, Inc. - Common Stock is 5.680
    When was Verastem, Inc. - Common Stock last traded?
    The last trade of Verastem, Inc. - Common Stock was at 02/19/26 09:30 AM ET
    What is the market capitalization of Verastem, Inc. - Common Stock?
    The market capitalization of Verastem, Inc. - Common Stock is 254.37M
    How many shares of Verastem, Inc. - Common Stock are outstanding?
    Verastem, Inc. - Common Stock has 254M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.